UAE

The ISO standard evaluates the entire diagnostic process, from sample collection to reporting, ensuring laboratories consistently produce reliable results.

The transaction concludes a phased investment strategy that steadily increased Amanat’s control over the group.

Jascayd® acts as a selective inhibitor of phosphodiesterase-4B (PDE4B), a biological pathway linked to inflammation and fibrotic processes in the lungs.

The award places the Centre among the leading innovators in healthcare, particularly in neurotechnology and personalised rehabilitation.

The agreements aim to strengthen national health security and create a coordinated response system that can manage future emergencies more effectively.

Under this agreement, CellSave Arabia will act as the exclusive provider of cord blood, cord tissue, placental tissue, cord vessel, and amnion preservation services.

The care model integrates internationally recognised diagnostic frameworks such as ADOS for autism assessment, WISC for cognitive evaluation, and Conners Rating Scales for ADHD screening.

The designation highlights Abu Dhabi’s expanding role in global health security, particularly in strengthening systems that detect, track, and respond to infectious disease threats.

The agreement was formalised during a signing ceremony held at ADCAN Pharma’s advanced manufacturing facility in Abu Dhabi, bringing together senior leadership from both organisations and key healthcare stakeholders.

Neurodiversity remains a central focus, particularly in identifying autism and ADHD in girls, women, and high-achieving adults who often mask symptoms for years before receiving support.